|
(Kingston, ON) A surprising discovery by Queen's
researchers helps explain why fish swimming in icy sea water don't
freeze.
The team, led by Biochemistry Professor Peter
Davies, has identified a new "antifreeze" protein found in the blood
of winter flounder enabling the fish to withstand temperatures as low
as -1.9 degrees Celsius: the freezing point of sea water. The
antifreeze plasma proteins (AFPs) do this by binding irreversibly to
ice crystals and preventing them from growing.
Until now, it has been a mystery how these fish
survive in polar oceans, since the previously identified "type I" AFP
associated with winter flounder only provides 0.7oC of freezing point
depression, which in combination with blood solutes, only protects the
fish down to -1.5 degrees Celsius.
"This finally explains the 'critical gap' of 0.4
degrees," says Dr. Davies, a Queen's Canada Research Chair in Protein
Engineering. "The winter flounder has been studied extensively by a
number of laboratories over the past 30 years, but this antifreeze
protein escaped everyone's notice. We're excited to have found it."
The research, conducted with Christopher Marshall
from Queen's Department of Biochemistry and Garth Fletcher from the
Ocean Sciences Centre at Memorial University, is published today in
the journal Nature.
The team used a process called ice affinity
purification to identify the new protein. "When you grow a 'popsicle'
of ice in the presence of these proteins, the AFPs bind to the ice and
become included, while other proteins are excluded," explains Mr.
Marshall. "Lemon-shaped ice crystals that differed significantly from
the hexagon-shaped crystals obtained with type I AFPs told us that we
were dealing with an unknown antifreeze protein."
The new protein is extraordinarily active in
comparison with other fish antifreeze proteins. At room temperature
and at low pH values, however, it loses all activity perhaps
explaining why it remained undetected for three decades. "Prior to
this we had only found such hyperactive antifreeze proteins in insects,"
says Dr. Davies.
Being able to control the growth of ice crystals
could have a number of bio-technological and medical applications, the
researchers suggest.
AFPs have been tested in the storage of organs and
blood products for transplantation, where they offer protection
against freezing, improving viability and extending maximum storage
periods. They have also been applied in cryosurgery, a technique in
which tumor cells are killed by freezing, because AFPs modify the
shape of ice crystals into more destructive spicules.
This finding also opens the possibility of
transferring genes from winter flounder into salmon, for example, to
make them more freeze-resistant for fish farming, or into crops to
make them more frost-resistant to extend their growing season. These
applications could be realized with concentrations of hyperactive AFPs
10 to 100-fold lower than would be required with the previously
discovered fish AFPs. |